Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education

By Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Saima Hedrick, Virginia Pappas, Maria C. Carrillo, Dean M. Hartley Abstract: Amyloid PET imaging is a novel diagnostic test that can detect in living humans one of the two defining pathologic lesions of Alzheimer disease, amyloid-β deposition in the brain. The Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging previously published appropriate Read & Research Alzheimer’s More

Leave a Reply